Clinical Trials Logo

Clinical Trial Summary

This will be an open-label trial in Burkina Faso assessing the pharmacokinetics of the antimalarial combination of dihydroartemisinin/piperaquine (DP, Duocotexcin) in children. Dihydroartemisinin-piperaquine is a promising candidate for first-line therapy of malaria. We hypothesize that the disposition and pharmacokinetics of DP will be altered in children, and this will alter the efficacy and/or toxicity of DP. We will test this hypothesis in this open-label trial in Burkina Faso. The target population includes residents, aged 6 months to 10 years in Bobo-Dioulasso. Children who present to the study clinics with symptoms suggestive of malaria will be screened with a thick blood smear. Subjects who meet selection criteria of treatment efficacy will be treated and followed up for 42 days. Pharmacokinetic sampling for DP will occur on selected follow-up days.


Clinical Trial Description

n/a


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT00845533
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase Phase 4
Start date August 2007
Completion date January 2009

See also
  Status Clinical Trial Phase
Recruiting NCT00540202 - Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children Phase 4
Completed NCT02787070 - A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI) Phase 4
Completed NCT01213433 - Amodiaquine+Artesunate for Uncomplicated Malaria Treatment Phase 4
Active, not recruiting NCT00406146 - Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children Phase 3
Completed NCT05192265 - Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine Phase 2/Phase 3
Completed NCT04767191 - Malaria Therapeutic Efficacy Study (TES) Kenya Phase 4
Completed NCT04767217 - Malaria Therapeutic Efficacy Study, Rwanda Phase 4
Completed NCT06036030 - Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua Phase 2
Recruiting NCT06064591 - Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Completed NCT06300970 - Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia Phase 4
Not yet recruiting NCT05911828 - A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers Phase 1
Completed NCT03387631 - Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania N/A
Completed NCT00868465 - Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) N/A
Completed NCT00460369 - Treatment of Uncomplicated Malaria in Benin N/A
Completed NCT00459615 - Phase II Dose Ranging Study of Artesunate Phase 2